Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Adams

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnosticsAnn-Charlott Steffen, Maria Wikman, Vladimir Tolmachev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug ResistanceRachelle L Dillon, Shilpa Chooniedass, Arjune Premsukh, et al.
Sensors (Basel, Switzerland)|March 14, 2012
A rapid method to regenerate piezoelectric microcantilever sensors (PEMS)LiNa Loo, Wei Wu, Wan Y Shih, et al.
Molecular Cancer Therapeutics|August 25, 2006
Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancerQing-an Yuan, Heidi H Simmons, Matthew K Robinson, et al.
Molecules (Basel, Switzerland)|December 22, 2016
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule AgentsShilpa Chooniedass, Rachelle L Dillon, Arjune Premsukh, et al.
Plos One|April 25, 2013
Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinomaPeirong Chen, Shoko Nogusa, Roshan J Thapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2006
Affibody-mediated tumour targeting of HER-2 expressing xenografts in miceAnn-Charlott Steffen, Anna Orlova, Maria Wikman, et al.
Journal of Molecular Biology|July 3, 2007
Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cellsYu Zhou, Daryl C Drummond, Hao Zou, et al.
Nuclear Medicine and Biology|August 21, 2007
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody moleculeErika Nordberg, Mikaela Friedman, Lovisa Göstring, et al.
Cancer Research|March 1, 2005
Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabodyMatthew K Robinson, Mohan Doss, Calvin Shaller, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnosticsAnn-Charlott Steffen, Maria Wikman, Vladimir Tolmachev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug ResistanceRachelle L Dillon, Shilpa Chooniedass, Arjune Premsukh, et al.
Sensors (Basel, Switzerland)|March 14, 2012
A rapid method to regenerate piezoelectric microcantilever sensors (PEMS)LiNa Loo, Wei Wu, Wan Y Shih, et al.
Molecular Cancer Therapeutics|August 25, 2006
Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancerQing-an Yuan, Heidi H Simmons, Matthew K Robinson, et al.
Molecules (Basel, Switzerland)|December 22, 2016
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule AgentsShilpa Chooniedass, Rachelle L Dillon, Arjune Premsukh, et al.
Plos One|April 25, 2013
Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinomaPeirong Chen, Shoko Nogusa, Roshan J Thapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2006
Affibody-mediated tumour targeting of HER-2 expressing xenografts in miceAnn-Charlott Steffen, Anna Orlova, Maria Wikman, et al.
Journal of Molecular Biology|July 3, 2007
Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cellsYu Zhou, Daryl C Drummond, Hao Zou, et al.
Nuclear Medicine and Biology|August 21, 2007
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody moleculeErika Nordberg, Mikaela Friedman, Lovisa Göstring, et al.
Cancer Research|March 1, 2005
Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabodyMatthew K Robinson, Mohan Doss, Calvin Shaller, et al.
Pageof 4